CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $480.53 | $211K | 333,303 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $481.47 | $289K | 332,703 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $482.35 | $193K | 332,303 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $483.69 | $39K | 332,223 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $485.16 | $116K | 331,983 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −411 | $486.72 | $200K | 331,572 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,429 | $487.87 | $697K | 330,143 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,604 | $488.68 | $784K | 328,539 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,114 | $489.62 | $1.5M | 325,425 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −940 | $490.50 | $461K | 324,485 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −42 | $491.25 | $21K | 324,443 |
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −8,910 | 0 | ||
| 2026-09-03 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −590 | 499,410 | ||
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,545 | $478.93 | $740K | 51,927 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −936 | $479.66 | $449K | 50,991 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,360 | $480.86 | $1.1M | 48,631 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,048 | $481.92 | $505K | 47,583 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −160 | $482.66 | $77K | 47,423 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $483.85 | $97K | 47,223 |
Page 41 of 121 · 2,404 trades